+ All Categories
Home > Documents > carcinogenesis cqrcinogenic agents 2010

carcinogenesis cqrcinogenic agents 2010

Date post: 04-Apr-2018
Category:
Upload: mutiana-muspita-jeli
View: 213 times
Download: 0 times
Share this document with a friend

of 39

Transcript
  • 7/29/2019 carcinogenesis cqrcinogenic agents 2010

    1/39

    28/11/2005 tums-pafkugm 1

    Carcinogenesis,

    Carcinogenic Agentsand

    Their Cellular Interaction

  • 7/29/2019 carcinogenesis cqrcinogenic agents 2010

    2/39

    28/11/2005 tums-pafkugm 2

    Carcinogenesis

    A large number of agents cause geneticdamage and induce neoplastic

    transformation of cells Chemical Carcinogens

    Radiant energy

    Oncogenic viruses and some othermicrobes

  • 7/29/2019 carcinogenesis cqrcinogenic agents 2010

    3/39

    28/11/2005 tums-pafkugm 3

  • 7/29/2019 carcinogenesis cqrcinogenic agents 2010

    4/39

    28/11/2005 tums-pafkugm 4

    Experimental model: Normal Cells

    INITIATION

    PROMOTION

    Cancer Cells

    Chemical Carcinogenesis

  • 7/29/2019 carcinogenesis cqrcinogenic agents 2010

    5/39

    28/11/2005 tums-pafkugm 5

    Chemical Carcinogenesis is a

    Multistep ProcessStages of Chemical Carcinogenesis

    Initiation, likely represents a mutation in a single cell

    Promotion, follows initiation and reflects the clonalexpansion of the initiated cells, and maintain it

    Progression, is the stage in which growth becomeautonomous, by this time, sufficient mutations haveaccumulated to immortalize cells

    Cancer, the end result of the entire sequence

  • 7/29/2019 carcinogenesis cqrcinogenic agents 2010

    6/39

    28/11/2005 tums-pafkugm 6

    Initiation-promotion scheme

  • 7/29/2019 carcinogenesis cqrcinogenic agents 2010

    7/39

    28/11/2005 tums-pafkugm 7

    INITIATION

    Initiator alone is not sufficient for tumorformation (Group 1)

    Initiation results from exposure of cells to an

    appropriate dose of initiator (carcinogenicagents)

    Initiation irreversible mutation (DNAdamage) memory months later

    +promoter tumor (Group 2&3)

  • 7/29/2019 carcinogenesis cqrcinogenic agents 2010

    8/39

    28/11/2005 tums-pafkugm 8

    PROMOTION

    promoter is non-tumorigenic by itself

    Induce tumors in initiated cells (Group 5)

    When promoter is applied before initiator, no

    tumor developed (Group 4) When the time between multiple application is

    extended the effect of promoter is reversible

    tumors failed to develop (Group 6)

  • 7/29/2019 carcinogenesis cqrcinogenic agents 2010

    9/39

    28/11/2005 tums-pafkugm 9

    Initiation

    &

    Promotion

  • 7/29/2019 carcinogenesis cqrcinogenic agents 2010

    10/39

    28/11/2005 tums-pafkugm 10

    Initiation&

    promotion

  • 7/29/2019 carcinogenesis cqrcinogenic agents 2010

    11/39

    28/11/2005 tums-pafkugm 11

    Events in ChemicalCarcinogenesis

  • 7/29/2019 carcinogenesis cqrcinogenic agents 2010

    12/39

    28/11/2005 tums-pafkugm 12

    Major Chemical Carcinogen

    Direct-acting Carcinogens

    Alkylating Agents

    Acylating agents

    Procarcinogen that Require Metabolic activation Polycyclic & Heterocyclic Aromatic Hydrocarbons

    Aromatic Amines, Amides, Azo Dyes

    Natural Plant and Microbial Products Others

  • 7/29/2019 carcinogenesis cqrcinogenic agents 2010

    13/39

    28/11/2005 tums-pafkugm 13

    Chemical Carcinogens are MostlyMutagen

    A mutagen is an agent that can permanently alter thegenetic constitution of a cell

    A mutagen is not necesserily a carcinogen

    Cell culture good method to study:

    - mutation, assays of mutagenicity

    - unscheduled DNA synthesis

    - DNA strand breaks- Screening for carcinogenic potential of chemicals

  • 7/29/2019 carcinogenesis cqrcinogenic agents 2010

    14/39

    28/11/2005 tums-pafkugm 14

    Initiation of Carcinogenesis

    1. Direct acting compound do not require chemicaltransformation for their carcinogenicity

    2. Indirect acting compound / procarcinogen, requiremetabolic conversion in vivo to produce ultimatecarcinogen

    Property in common:

    = They are highly reactive electrophiles that can reactwith nucleophilic sites in the cell electrophilic

    reaction sub-lethal damage to DNA

    = Molecularfingerprint

  • 7/29/2019 carcinogenesis cqrcinogenic agents 2010

    15/39

    28/11/2005 tums-pafkugm 15

    Carcinogen tumor types (fingerprinting)

  • 7/29/2019 carcinogenesis cqrcinogenic agents 2010

    16/39

    28/11/2005 tums-pafkugm 16

    Promoters

    Promoters: phorbol esters, hormone, phenols,drugs

    Not mutagenic how do they contribute totumorigenesis study of TPA (tetradecanoyl

    phorbol-13 acetate) TPA: - phorbol esters

    - powerful activator for protein kinase C, an

    enzyme that phophorylates several

    substrates involved in signal transductionpathways

  • 7/29/2019 carcinogenesis cqrcinogenic agents 2010

    17/39

    28/11/2005 tums-pafkugm 17

    Tumor Promotion

    Application of promoter leads to proliferation andclonal expansion of initiated (mutated) cells

    Initiated cells respond differently to promoters thando normal cells and hence expand selectively

    Tumor promotion includes multiple steps:

    - Proliferation of preneoplastic cells

    - Malignant conversion

    - Tumor progression

  • 7/29/2019 carcinogenesis cqrcinogenic agents 2010

    18/39

    28/11/2005 tums-pafkugm 18

    AflatoxinCarcinogenesis

  • 7/29/2019 carcinogenesis cqrcinogenic agents 2010

    19/39

    28/11/2005 tums-pafkugm 19

    Metal Carcinogen Metals/metal compounds can induce cancer, but the

    mechanism is unkown Divalent metal cations (Ni++, Pb++, Cd++, Co++, Be++) are

    electrophilic possible to react with macromolecules

    Metal ions react with guanin and phosphate group of

    DNA Metal ions can depolymerize polynucleotides

    Bind to purine and pyrimidine bases through covalentbinding

    Most metal-induced cancers occur in an occupationalsetting

    How do they occur in vivo is not known

  • 7/29/2019 carcinogenesis cqrcinogenic agents 2010

    20/39

    28/11/2005 tums-pafkugm 20

    Radiation Carcinogenesis

    Transform all kind of cells in vitro and induce neoplasms

    in vivo, in human & experimental animal

    UV light skin cancer

    Ionizing radiation of medical, occupational, and bomb of

    origins produce a variety of malignant neoplasms

    The effect of UV light is somewhat differ from those ofionizing radiation

  • 7/29/2019 carcinogenesis cqrcinogenic agents 2010

    21/39

    28/11/2005 tums-pafkugm 21

    UV

    UV effects on cells inhibition of cell division,inactivation of enzymes, induction of mutation, and

    killing the cells

    UV type:

    - UVA (320 400 nm): non-mutagenic- UVB (280 320 nm): mutagen, not filtered by ozone

    - UVC (200 280 nm): mutagen, filtered by ozone

    Type of cancer results are skin cancers: SCC, BCC,

    melanoma UVB also causes mutation in oncogenes (ras) and

    tumor suppressor genes (p53)

  • 7/29/2019 carcinogenesis cqrcinogenic agents 2010

    22/39

    28/11/2005 tums-pafkugm 22

    The carcinogenicity of UVB is attributed to itsformation of pyrimidine dimers in DNA

    This DNA damage is repaired by NER(nucleotide excision repair)

    1. Recognition of the DNA lesion

    2. Incision of the damage strand on both sitesof the

    lesion

    3. Removal of the damage nucleotide

    4. Synthesis of a nucleotide patch5. Synthesis of its ligation

  • 7/29/2019 carcinogenesis cqrcinogenic agents 2010

    23/39

    28/11/2005 tums-pafkugm 23

    The Formation of

    Pyrimidine Dimers of the DNA May between thymine & thymine, thymine &

    cytosine, cytosine pairs alone leads to

    cyclobutane ring distort the phosphodiesterbackbone of the double helix in the region of

    each dimer

    Unless repaired by NER genomic mutation

    produced by UV radiation is mutagenic and

    carcinogenic

  • 7/29/2019 carcinogenesis cqrcinogenic agents 2010

    24/39

    28/11/2005 tums-pafkugm 24

    NER (nucleotide excision repair)

    This process needs at least the product of 20

    genes

    Postulation: excessive sun exposure capacity

    of NER pathway in overwhelmed some DNAdamage remains unrepaired large

    transcription errors cancer

    Xeroderma pigmentosum (photosensitivity, 200-

    fold risk of ckin cancer) has several mutated

    genes involved in NER

  • 7/29/2019 carcinogenesis cqrcinogenic agents 2010

    25/39

    28/11/2005 tums-pafkugm 25

    Ionizing Radiation

    Electromagnetic radiation

    - X-rays and gamma rays

    Particulate radiation

    - particles, particles, proton,

    neutron

  • 7/29/2019 carcinogenesis cqrcinogenic agents 2010

    26/39

    28/11/2005 tums-pafkugm 26

    Hierarchy of Vulnerability

    1. Leukemia

    2. Thyroid

    3. Breast, lung, salivary gland(intermediate)

    4. Skin, bone, gastrointestinal tract

    (relatively resistant)

  • 7/29/2019 carcinogenesis cqrcinogenic agents 2010

    27/39

    28/11/2005 tums-pafkugm 27

    Viral & Microbial Oncogenesis

    Virus: DNA & RNA (retrovirus/oncorna virus),some carry oncogene, some dont

    Microbial Helicobacter pylori

  • 7/29/2019 carcinogenesis cqrcinogenic agents 2010

    28/39

    28/11/2005 tums-pafkugm 28

    Virus DNA

    A Cytopathic Virus The virus is integrated into the host

    genom cell transformation

    The integrated genes by the virus whichproduce cell transformation expressed

    inside transformed cells

    The important viruses: HPV, EBV, HBV,KSHV

  • 7/29/2019 carcinogenesis cqrcinogenic agents 2010

    29/39

    28/11/2005 tums-pafkugm 29

    HPV (Human Papilloma Virus)

    High risk: strain 16, 18, and the less found arestrain 31, 33, 35, dan 51 invasive SCC (85%)with the tumor precursors: severe dysplasia andin situ Ca

    Low risk: the dominant are 6 & 11 genital wartwith low malignant potential

    Strain 1, 2, 4, 7 papilloma

    Oncoprotein from type 16 & 18 can interact

    (binding) with p53 and pRb with high affinitycell transformation

  • 7/29/2019 carcinogenesis cqrcinogenic agents 2010

    30/39

    28/11/2005 tums-pafkugm 30

    Effect of HPV Protein E6 & E7 onthe Cell Cycle

  • 7/29/2019 carcinogenesis cqrcinogenic agents 2010

    31/39

    28/11/2005 tums-pafkugm 31

    EBV(Epstein Barr virus) Has role in the pathogenesis tumor: lymphoma

    Burkitt (African form), B cell lymphoma in personwith immunosuppression, Hodgkin lymphoma,and NPC

    EBV infects oropharynx epithelial and the B cell

    (via receptor CD21) cell immortalization Oncoprotein: LMP-1 inhibit apoptosis by up-

    regulating bcl-2, and activates growth-promotingpathways

    EBNA-2: transactivation several host genes(cyclin D and srcfamily members), and activatetranscription of LMP-1

  • 7/29/2019 carcinogenesis cqrcinogenic agents 2010

    32/39

    28/11/2005 tums-pafkugm 32

    Virus DNA onkogenik

    EBV

    Translocation of MYC(mutation)

    Limfoma Burkitt

  • 7/29/2019 carcinogenesis cqrcinogenic agents 2010

    33/39

    28/11/2005 tums-pafkugm 33

    HBV(Hepatitis B Virus) HBV infection increases the risk of the

    development of HCC 200X

    The virus is integrated into the liver cell genom, but

    not developing oncoprotein no consistent pattern

    of oncogenesis maybe the effects are indirect:1. Chronic inflammation cirrhosis regenerative

    hyperplasia

    2. HBV codes the protein HBx

    destroy normaldevelopment control

    3. HBx binding to p53 inactivated suppresion

  • 7/29/2019 carcinogenesis cqrcinogenic agents 2010

    34/39

    28/11/2005 tums-pafkugm 34

    KSHV (Kaposi Sarcoma Herpes Virus)

    Ther member of herpes virus family

    Etiological factor etiology for Kaposi sarcomaespecially in the imunodefficient individuals(AIDS)

    The basic pathogenesis is multifactorial:

    1. Severe T cell imunity defect

    2. Disregulation of B cell and monocyte

    3. Multiple known viral infection (HHV type8, EBV, HPV), and unknown virus

  • 7/29/2019 carcinogenesis cqrcinogenic agents 2010

    35/39

    28/11/2005 tums-pafkugm 35

    Retrovirus: HTLV-1

    Human T-cell Leukemia Virus Type 1

    the onethat recognized oncogenic to human (a lot in

    animal)

    The tendency of infection to limfocyte CD4+

    Sexual intercourse infection, blood, breast-

    feeding

    Leukemia: only 1% of all infected person after

    latent period of 20-30 years

  • 7/29/2019 carcinogenesis cqrcinogenic agents 2010

    36/39

    28/11/2005 tums-pafkugm 36

    Retrovirus

    HTLV-1

    Is a lymphotrophic agent

  • 7/29/2019 carcinogenesis cqrcinogenic agents 2010

    37/39

    28/11/2005 tums-pafkugm 37

    Helicobacter pylori

    Carcinoma

    Lymphoma

    Strong relationship

    Epidemiologic study:

    - Detection of HP infection in the

    great majority of gastric lymphoma

    - Treatment of HP infection with anti-

    biotics results in regression of the

    lymphoma in most cases

    Infection

    Only 20-30% : ulcers

  • 7/29/2019 carcinogenesis cqrcinogenic agents 2010

    38/39

    28/11/2005 tums-pafkugm 38

    Helicobacter pylori

    The strain causing disease contain pathogenic islandcontaining CagA (cytotoxin associated gene A) andsecretory system injects the CagA protein into thehost cells

    Gene associated with virulence: VacA (encodevacuolated toxin that causes apoptosis)

    The infection is associated with adenocarcinomas of the

    intestinal type (sequence: chronic gastritis multifocal

    atrophy with lower gastric acid secretion intestinal

    metaplasia dysplasia carcinoma)

  • 7/29/2019 carcinogenesis cqrcinogenic agents 2010

    39/39

    28/11/2005 t fk 39

    Gastric Lymphoma(mucosal associated lymphoid tissue / MALT MALTOMA)

    -The B-cell that give rise to this tumor normally

    reside in the marginal zone marginal zonelymphoma

    -Infection lymphoid infiltrates B-cells actively

    proliferate may acquire genetic abnormalities

    such as 11;18 translocation


Recommended